Vitamin D and Warfarin Management
Vitamin D Supplementation for Level of 11 ng/mL
For a vitamin D level of 11 ng/mL (severe deficiency), start with 50,000 IU of vitamin D3 (cholecalciferol) once weekly for 12 weeks, then transition to maintenance therapy with 2,000 IU daily. 1
Loading Phase Protocol
- Severe deficiency (<12 ng/mL) requires aggressive repletion with 50,000 IU weekly for 12 weeks rather than the standard 8 weeks used for moderate deficiency 1
- Vitamin D3 (cholecalciferol) is strongly preferred over vitamin D2 (ergocalciferol) because it maintains serum levels longer and has superior bioavailability 1
- This regimen should increase the 25(OH)D level by approximately 40-70 ng/mL, bringing the patient to at least 51-81 ng/mL if responding normally 1
Essential Co-Interventions
- Ensure calcium intake of 1,000-1,500 mg daily from diet plus supplements if needed, as adequate calcium is necessary for clinical response to vitamin D therapy 1
- Calcium supplements should be taken in divided doses of no more than 600 mg at once for optimal absorption 1
- Take vitamin D with the largest, fattiest meal of the day to maximize absorption 1
Maintenance Phase After Loading
- Transition to 2,000 IU daily after completing the 12-week loading regimen 1
- Alternative maintenance option: 50,000 IU monthly (equivalent to approximately 1,600 IU daily) 1
Monitoring Protocol
- Recheck 25(OH)D levels at 3 months (after completing the loading phase) to confirm adequate response, as vitamin D has a long half-life and needs time to plateau 2
- Target level should be at least 30 ng/mL for optimal health benefits, particularly for anti-fracture efficacy 1
- If levels remain below 30 ng/mL at 3 months, increase maintenance dose by 1,000-2,000 IU daily 1
Warfarin Dose Adjustment for INR 1.9
For a patient taking warfarin 1 mg twice daily (2 mg total daily) with an INR of 1.9, increase the total daily dose by 10-20% (add 0.2-0.4 mg daily) and recheck INR in 3-5 days.
Understanding the Clinical Context
- An INR of 1.9 is subtherapeutic for most indications requiring anticoagulation (target typically 2.0-3.0) 3
- The current total daily dose of 2 mg is relatively low, suggesting the patient may be warfarin-sensitive or just beginning therapy 3
Dose Adjustment Strategy
- Increase total daily warfarin dose by 10-20%, which translates to adding 0.2-0.4 mg to the daily total 3
- Practical approach: Increase to 1.2 mg twice daily (2.4 mg total daily) as a 20% increase 3
- Alternative: Increase to 1 mg in the morning and 1.25 mg in the evening (2.25 mg total daily) as a 12.5% increase 3
Monitoring After Dose Change
- Recheck INR in 3-5 days after the dose adjustment to assess response 3
- Continue monitoring INR at least weekly until stable therapeutic range is achieved 3
Critical Vitamin K Interaction Warning
- The vitamin D supplementation prescribed above will NOT significantly affect warfarin dosing, as vitamin D and vitamin K are different vitamins 3, 4
- However, counsel the patient to maintain consistent dietary vitamin K intake (found in green leafy vegetables), as intake >250 mcg/day can decrease warfarin sensitivity and require higher doses 4
- Avoid sudden large changes in vitamin K-rich foods, as this affects INR stability 4
Important Safety Considerations
- Do not give vitamin K to correct this mildly subtherapeutic INR, as vitamin K is reserved for INR >4.5-5.0 or active bleeding 5
- Small oral vitamin K doses (1-2.5 mg) are appropriate for INR 5.0-9.0 without bleeding 3
- For INR >10.0, use 5 mg oral vitamin K 3